ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,408Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 2170

$2.12M Total Retail Price of All Prescriptions

Rank: 9 out of 2170

723 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 723 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 723 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 26,939 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 1,174 927 1 3
DONEPEZIL HCL 1,054 985 2 32
OMEPRAZOLE 949 810 3 2
AMLODIPINE BESYLATE 924 814 4 4
SIMVASTATIN 841 638 5 1
METOPROLOL TARTRATE 840 659 6 10
LEVOTHYROXINE SODIUM 801 656 7 5
FUROSEMIDE 788 685 8 6
WARFARIN SODIUM 786 656 9 15
MIRTAZAPINE 715 649 10 46
SERTRALINE HCL 670 511 11 25
GABAPENTIN 660 462 12 14
NAMENDA 629 597 13 48
CITALOPRAM HBR 506 454 14 19
POTASSIUM CHLORIDE 492 426 15 16
TRAMADOL HCL 488 441 16 18
METFORMIN HCL 403 284 17 8
LANTUS 397 285 18 51
DIVALPROEX SODIUM 396 293 19 91
RISPERIDONE 375 270 20 73
CYMBALTA 355 221 21 44
NOVOLOG 330 236 22 98
PANTOPRAZOLE SODIUM 301 243 23 39
RANITIDINE HCL 299 229 24 40
QUETIAPINE FUMARATE 297 252 25 88
POLYETHYLENE GLYCOL 3350 291 241 26 63
CARVEDILOL 278 247 27 26
FAMOTIDINE 275 230 28 96
ESCITALOPRAM OXALATE 260 235 29 75
LEVETIRACETAM 246 188 30 109
HYDROCHLOROTHIAZIDE 239 188 31 9
TAMSULOSIN HCL 238 208 32 33
ADVAIR DISKUS 231 190 33 45
CLONIDINE HCL 227 201 34 54
ISOSORBIDE MONONITRATE ER 223 192 35 50
PREDNISONE 219 165 36 41
BACLOFEN 218 93 37 137
LEVOFLOXACIN 213 186 38 99
CLOPIDOGREL 209 163 39 37
EXELON 205 194 40 119
CARBIDOPA-LEVODOPA 200 200 41 110
CIPROFLOXACIN HCL 198 150 42 69
PROMETHAZINE HCL 196 163 R 43 70
ATORVASTATIN CALCIUM 191 163 44 12
TRAZODONE HCL 183 135 45 38
METOPROLOL SUCCINATE 172 142 46 13
IPRATROPIUM-ALBUTEROL 172 148 46 131
JANTOVEN 164 143 48 104
PLAVIX 163 136 49 58
HYDRALAZINE HCL 160 148 50 84
SPIRIVA 160 148 50 49
PAROXETINE HCL 158 123 52 65
KETOCONAZOLE 158 119 52 212
ATENOLOL 155 119 54 23
NITROFURANTOIN MONO-MACRO 148 134 55 196
ABILIFY 144 100 56 159
NEXIUM 138 105 57 22
GLIPIZIDE 136 110 58 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 135 105 59 95
SEROQUEL 135 107 59 168
FLUTICASONE PROPIONATE 134 97 61 30
KLOR-CON M20 134 110 61 68
DIGOXIN 133 130 63 72
SANTYL 133 106 63 221
PRAVASTATIN SODIUM 132 93 65 11
LABETALOL HCL 125 115 66 208
LANTUS SOLOSTAR 122 95 67 79
DIOVAN 122 94 67 53
LOSARTAN POTASSIUM 119 106 69 21
OXYBUTYNIN CHLORIDE ER 116 111 70 148
LEXAPRO 113 101 71 198
TRAVATAN Z 113 92 71 181
DOXYCYCLINE HYCLATE 113 75 71 100
OLANZAPINE 113 65 71 139
HYDROCODONE-ACETAMINOPHEN 113 105 S3 71 7
ALENDRONATE SODIUM 112 96 76 36
METOCLOPRAMIDE HCL 112 64 76 127
SPIRONOLACTONE 111 83 78 71
LIDODERM 109 104 79 162
DILTIAZEM 24HR CD 108 89 80 82
ALLOPURINOL 105 100 81 29
DIVALPROEX SODIUM ER 103 68 82 189
CEPHALEXIN 101 80 83 120
SYNTHROID 101 101 83 27
CARBAMAZEPINE 101 34 83 204
MELOXICAM 97 57 86 28
TRIAMCINOLONE ACETONIDE 92 57 87 128
LATANOPROST 92 83 87 194
CEFTRIAXONE 90 73 89 211
VENLAFAXINE HCL ER 89 63 90 97
PHENYTOIN 87 66 91 310
FINASTERIDE 86 83 92 122
AZITHROMYCIN 86 58 92 47
BENZTROPINE MESYLATE 86 41 R 92 172
CLONIDINE 86 64 92 263
NOVOLOG FLEXPEN 85 56 96 171
HALOPERIDOL 80 56 97 176
MUPIROCIN 79 55 98 177
NOVOLIN R 78 57 99 149
LAMOTRIGINE 78 65 99 136
SINGULAIR 73 65 101 85
KLOR-CON M10 72 69 102 132
TRANSDERM-SCOP 72 69 102 330
ZIPRASIDONE HCL 70 61 104 248
NYSTOP 69 49 105 219
AMOX TR-POTASSIUM CLAVULANATE 69 57 105 126
ZOLPIDEM TARTRATE 68 64 107 17
ROPINIROLE HCL 67 58 108 92
GEMFIBROZIL 65 56 109 121
PREDNISOLONE ACETATE 63 54 110 371
CYCLOBENZAPRINE HCL 63 28 R 110 52
HYDROXYZINE HCL 59 45 R 112 173
AMIODARONE HCL 59 52 112 235
PHENYTOIN SODIUM EXTENDED 57 39 114 142
BENAZEPRIL HCL 57 54 114 55
DILTIAZEM ER 57 38 114 133
MONTELUKAST SODIUM 57 39 114 157
CRESTOR 57 47 114 24
TOPIRAMATE 56 48 119 155
INSULIN SYRINGE 56 56 119 113
DETROL LA 56 54 119 257
ALBUTEROL SULFATE 56 35 119 167
RESTASIS 55 49 123 233
PERPHENAZINE 55 44 123 390
LYRICA 55 53 123 90
BUSPIRONE HCL 52 45 126 143
TAMIFLU 51 50 127 234
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.